Relative Adrenocortical Insufficiency Following Radioactive Iodine Therapy for Graves' Disease: A Report of Two Cases

Overview

Journal Int J Gen Med

Publisher Dove Medical Press

Specialty General Medicine

Date 2021 May 12

PMID 33976564

Authors

Hanxin Zhao

Yu Ruan

Affiliations

Soon will be listed here.

Abstract

Introduction: In recent years, radioactive iodine (RAI) therapy has become a main choice for Graves' disease. The rapid release of thyroid hormones following RAI may on occasion trigger severe events, such as thyroid storm or heart block. This study presents two cases of possible acute adrenocortical insufficiency precipitated by radioiodine therapy.

Case Presentation: Two females aged 65 and 19 years with long-standing Graves' disease underwent radioiodine treatment at our clinical center. Both patients suffered nausea, fatigue, aggravated palpitation, and relative hypotension thereafter. Laboratory data showed severe thyrotoxicosis with free thyroxine higher than three times the upper limit, while basal serum cortisol (8 AM) was below the lower limit (5.08 μg/dL and 2.08 μg/dL respectively) under stress, indicating a potential relative adrenocortical insufficiency. There was then full recovery after adequate hydrocortisone therapy. As thyrotoxicosis resolved, the levels of basal cortisol were subsequently raised to normal.

Conclusion: Post-RAI adrenocortical insufficiency might occur in patients with severe Graves' disease. Basal serum cortisol might be a cost-effective parameter for the identification of potential patients.

References

Price S, Thondam S, Bondugulapati L, Kamath C, Adlan M, Premawardhana L . Significant attenuation of stimulated cortisol in early Graves disease without adrenal autoimmunity. Endocr Pract. 2012; 18(6):924-30. DOI: 10.4158/EP12002.OR. View

Agbaht K, Gullu S . Adrenocortical reserves in hyperthyroidism. Endocrine. 2013; 45(1):136-43. DOI: 10.1007/s12020-013-9933-y. View

Happel C, Kranert W, Groner D, Baumgarten J, Halstenberg J, Bockisch B . Focus on radioiodine-131 biokinetics: the influence of methylprednisolone on intratherapeutic effective half-life of I during radioiodine therapy of Graves' disease. Endocrine. 2021; 73(1):125-130. PMC: 8211592. DOI: 10.1007/s12020-020-02593-x. View

Fallahi P, Ferrari S, Ragusa F, Ruffilli I, Elia G, Paparo S . Th1 Chemokines in Autoimmune Endocrine Disorders. J Clin Endocrinol Metab. 2019; 105(4). DOI: 10.1210/clinem/dgz289. View

Karl M, Onumah B, Cole J, Golding J, Burman K, Wartofsky L . Hypocortisolemia in Graves hyperthyroidism. Endocr Pract. 2009; 15(3):220-4. DOI: 10.4158/EP.15.3.220. View

Tsatsoulis A, Johnson E, Kalogera C, Seferiadis K, Tsolas O . The effect of thyrotoxicosis on adrenocortical reserve. Eur J Endocrinol. 2000; 142(3):231-5. DOI: 10.1530/eje.0.1420231. View

Teng W, Shan Z, Teng X, Guan H, Li Y, Teng D . Effect of iodine intake on thyroid diseases in China. N Engl J Med. 2006; 354(26):2783-93. DOI: 10.1056/NEJMoa054022. View

Bonnema S, Hegedus L . Radioiodine therapy in benign thyroid diseases: effects, side effects, and factors affecting therapeutic outcome. Endocr Rev. 2012; 33(6):920-80. DOI: 10.1210/er.2012-1030. View

Bartalena L, Baldeschi L, Boboridis K, Eckstein A, Kahaly G, Marcocci C . The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy. Eur Thyroid J. 2016; 5(1):9-26. PMC: 4836120. DOI: 10.1159/000443828. View

10.

Fredette M, Topor L . Graves' Thyrotoxicosis Leading to Adrenal Decompensation and Hyperandrogenemia in a Pediatric Patient with Salt-Wasting Congenital Adrenal Hyperplasia. Case Rep Endocrinol. 2019; 2018:2359205. PMC: 6282132. DOI: 10.1155/2018/2359205. View

11.

Nascif S, Molica P, Correa-Silva S, Silva M, Lengyel A . Ghrelin and GHRP-6-induced ACTH and cortisol release in thyrotoxicosis. Pituitary. 2009; 12(4):315-21. DOI: 10.1007/s11102-009-0181-3. View

12.

Hoshiro M, Ohno Y, Masaki H, Iwase H, Aoki N . Comprehensive study of urinary cortisol metabolites in hyperthyroid and hypothyroid patients. Clin Endocrinol (Oxf). 2006; 64(1):37-45. DOI: 10.1111/j.1365-2265.2005.02412.x. View

13.

Satoh M, Aso K, Ikehara S, Komine Y, Saji T . A 3-year-old girl with Graves' disease with hypoglycemia following transient adrenal hyporesponsiveness. J Pediatr Endocrinol Metab. 2012; 24(11-12):1047-50. DOI: 10.1515/jpem.2011.307. View

14.

Vennard K, Gilbert M . Thyroid Storm and Complete Heart Block after Treatment with Radioactive Iodine. Case Rep Endocrinol. 2018; 2018:8214169. PMC: 6016161. DOI: 10.1155/2018/8214169. View

15.

Annane D, Pastores S, Rochwerg B, Arlt W, Balk R, Beishuizen A . Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Intensive Care Med. 2017; 43(12):1751-1763. DOI: 10.1007/s00134-017-4919-5. View

16.

Attaye I, van Andel M, Kooter A . More, less or both?. BMJ Case Rep. 2018; 2018. PMC: 5847917. DOI: 10.1136/bcr-2017-222355. View

17.

Kim M, Kim B, Jang M, Kim J, Kim E, Jeon Y . High neutrophil-to-lymphocyte ratio is associated with relapse in Graves' disease after antithyroid drug therapy. Endocrine. 2019; 67(2):406-411. DOI: 10.1007/s12020-019-02137-y. View

18.

Weetman A . Autoimmune thyroid disease. Endocrine. 2020; 68(2):258-260. PMC: 7266799. DOI: 10.1007/s12020-020-02188-6. View

19.

Mizokami T, Hamada K, Maruta T, Higashi K, Tajiri J . Painful Radiation Thyroiditis after I Therapy for Graves' Hyperthyroidism: Clinical Features and Ultrasonographic Findings in Five Cases. Eur Thyroid J. 2016; 5(3):201-206. PMC: 5091234. DOI: 10.1159/000448398. View

20.

Johnson E, Kamilaris T, Calogero A, Gold P, Chrousos G . Experimentally-induced hyperthyroidism is associated with activation of the rat hypothalamic-pituitary-adrenal axis. Eur J Endocrinol. 2005; 153(1):177-85. DOI: 10.1530/eje.1.01923. View